← Eichor
Study identifier: NCT06438822 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma

Condition: Cholangiocarcinoma  ·  Sponsor: West China Hospital

PhasePhase 2
Planned participants51
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This study aimed to evaluate the efficacy and safety of the combination of cadonilimab with liposomal irinotecan plus fluorouracil and leucovorin for the treatment of advanced biliary tract cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Dan Cao  ·  86-28-85422589  ·  caodan@scu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

West China Hospital, Sichuan UniversityChengdu, Sichuan, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06438822